Skip to main navigation
Skip to content
Skip to content
PDL Logo Blue Green
  • About PDL
  • Leadership
  • Investor Relations
  • About PDL
    • Management
  • Portfolio of Assets
  • Investor Relations
  • News
  • Contact

SEC Filings

PDL  > Investor Relations > SEC Filings

SEC Filings

Filing date Form Description View
Mar 29, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
0000882104-21-000035.pdf
0000882104-21-000035.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 19, 2021 SC TO-I/A

Amendment to a previously filed SC TO-I

View HTML
0000882104-21-000030.pdf
0000882104-21-000030.xls
Feb 12, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000354204-21-000192.pdf
0000354204-21-000192.xls
Feb 11, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001037389-21-000129.pdf
Feb 11, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001104659-21-020719.pdf
0001104659-21-020719.xls
Feb 3, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001123292-21-000156.pdf
0001123292-21-000156.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000398.pdf
9999999995-21-000398.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000399.pdf
9999999995-21-000399.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000400.pdf
9999999995-21-000400.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000428.pdf
9999999995-21-000428.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000403.pdf
9999999995-21-000403.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000402.pdf
9999999995-21-000402.xls
Feb 3, 2021 EFFECT

EFFECT

View HTML
9999999995-21-000401.pdf
9999999995-21-000401.xls
Feb 2, 2021 POS AM

Post-effective amendment to an S-Type filing

View HTML
0000882104-21-000024.pdf
0000882104-21-000024.xls
Feb 2, 2021 POS AM

Post-effective amendment to an S-Type filing

View HTML
0000882104-21-000023.pdf
0000882104-21-000023.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

    Investor Relations

    • Frequently Asked Questions (FAQ)
    • Investor Updates
    • Press Releases
    • 2020 Proxy Statement
    • Tax Information
      • Common Stock Tax Information
      • Convertible Note Tax Information
    • SEC Filings
    • Contact Information

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • RSS
    • Print
    • Share
    • Search
    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

PDL Logo White Fill

  • Terms of Use
  • Sitemap
© Copyright 2021 PDL BioPHARMA. All Rights Reserved.